Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

New yohimbine analogues synthesized at the University of Florida

Nov. 15, 2017

Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics

Nov. 3, 2017

Novel leukotriene A-4 hydrolase inhibitors identified at Novartis

Oct. 31, 2017

Allergan presents new fMet-Leu-Phe receptor modulators

Oct. 30, 2017

University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors

Oct. 19, 2017

Blade Therapeutics patents novel calpain inhibitors

Oct. 4, 2017

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation

Sep. 19, 2017

FDA issues complete response letter for Ryanodex

July 27, 2017

Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors

July 12, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.